1. Home
  2. XENE vs FHI Comparison

XENE vs FHI Comparison

Compare XENE & FHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xenon Pharmaceuticals Inc.

XENE

Xenon Pharmaceuticals Inc.

SELL

Current Price

$38.80

Market Cap

3.7B

Sector

Health Care

ML Signal

SELL

Logo Federated Hermes Inc.

FHI

Federated Hermes Inc.

SELL

Current Price

$61.12

Market Cap

4.3B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
XENE
FHI
Founded
1996
1955
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
4.3B
IPO Year
2014
1998

Fundamental Metrics

Financial Performance
Metric
XENE
FHI
Price
$38.80
$61.12
Analyst Decision
Strong Buy
Hold
Analyst Count
18
8
Target Price
★ $71.56
$61.00
AVG Volume (30 Days)
★ 1.2M
737.4K
Earning Date
11-09-2026
10-29-2026
Dividend Yield
N/A
★ 2.42%
EPS Growth
N/A
★ 58.82
EPS
N/A
★ 4.15
Revenue
$311,000.00
★ $1,102,924,000.00
Revenue This Year
N/A
$10.62
Revenue Next Year
$1,985.11
$3.61
P/E Ratio
★ N/A
$15.13
Revenue Growth
N/A
★ N/A
52 Week Low
$33.38
$47.30
52 Week High
$72.66
$67.38

Technical Indicators

Market Signals
Indicator
XENE
FHI
Relative Strength Index (RSI) 47.51 50.30
Support Level $33.38 $53.95
Resistance Level $39.92 $66.80
Average True Range (ATR) 1.44 2.11
MACD 0.45 -0.06
Stochastic Oscillator 39.58 39.31

Price Performance

Historical Comparison
XENE
FHI

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About FHI Federated Hermes Inc.

Federated Hermes provides asset management services for institutional and individual investors. The firm had $911.6 billion in managed assets at the end of the second quarter of 2026, composed of equity (12%), multi-asset (less than 1%), fixed-income (11%), alternative (2%), and money market (74%) funds. The company's cash management operations are expected to generate around 52% of Federated's revenue this year, compared with 30%, 10%, and 8%, respectively, for the equity, fixed-income, and alternatives/multi-asset/other operations. The company's products are distributed via trust banks, wealth managers, and retail broker/dealers (67% of AUM), institutional investors (26%), and international clients (7%).

Share on Social Networks: